Anakinra is named as a drug or biological intervention in 4 clinical trials in our India, China and Ireland trial registers, 3 of which are recruiting. Lead sponsors include UMC Utrecht (1), University of Oxford (1) and Beijing Tiantan Hospital (1). Registered phases: Phase 3, Phase 2 and Observational. Conditions studied include Community-acquired Pneumonia, Influenza, COVID-19; Pneumonia; Stroke Acute.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT02735707 | Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia Community-acquired Pneumonia, Influenza, COVID-19 |
Phase 3 | Recruiting |
| NCT04381936 | Randomised Evaluation of COVID-19 Therapy (ClinicalTrials.gov ↗) Pneumonia |
Phase 3 | Recruiting |
| NCT07191444 | A Study of Firsekibart Versus Anakinra in Adult-Onset Still's Disease (ClinicalTrials.gov ↗) Still's Disease, Adult-Onset |
Observational | Recruiting |
| NCT07423975 | Advancing Reperfusion Therapy for Ischemic Stroke: Safety and Efficacy of Anakinra for Futile Reperfusion Following Endovascular Treatment in Patients With Acute Ischemic Stroke (ClinicalTrials.gov ↗) Stroke Acute, Endovascular Treatment |
Phase 2 | Not yet open |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Community-acquired Pneumonia, Influenza, COVID-19 | 1 |
| Pneumonia | 1 |
| Stroke Acute | 1 |
| Endovascular Treatment | 1 |
| Still's Disease, Adult-Onset | 1 |
| Lead sponsor | Trials |
|---|---|
| UMC Utrecht | 1 |
| University of Oxford | 1 |
| Beijing Tiantan Hospital | 1 |
| Ruijin Hospital | 1 |
| Register | Anakinra trials |
|---|---|
| Clinical trials in India | 2 |
| Clinical trials in China | 2 |
| Clinical trials in Ireland | 1 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Anakinra works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Anakinra (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.